Aleph Alpha, a European rival to OpenAI, is in talks amid AI boom to raise up to $100 million in new funding, sources say
Generative-AI startup Aleph Alpha is in talks with investors over a new funding round, sources said.Founded in 2019, the company wants to be Europe's answer to OpenAI.
Aleph Alpha, a German generative AI startup, is in talks with investors over a new funding round, Insider has learned. The startup, based in Heidelberg, Germany, is talking to a number of top-tier VC investors over a round that could be as much as $100 million, four sources familiar with the matter told Insider.
It comes amid a wave of investor hype in the AI market after US startup OpenAI released ChatGPT, based on its GPT-3.5 language model which was trained on Azure, to the public in November.
Österreich Neuesten Nachrichten, Österreich Schlagzeilen
Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.
ChatGPT's OpenAI hired tons of ex-Google, Meta staff, per new dataInsider tells the global tech, finance, markets, media, healthcare, and strategy stories you want to know.
Weiterlesen »
OpenAI's GPT-3 vs. chatGPT: Writer compares chatbot versionsI tried OpenAI's ChatGPT 2 years ago. I'm terrified by how far it's come and think it could change my job.
Weiterlesen »
Yelp staff flocked to Texas, Florida after it closed NYC, SF officesYelp workers flocked to Texas and Florida from New York and San Francisco after the company went fully remote
Weiterlesen »
Starbucks CEO said unions don't have a place at the companyStarbuck's interim CEO Howard Schultz said he doesn't believe unions have a place at the coffee giant as unionization efforts spread
Weiterlesen »
How to invest in artificial intelligence: Stock picks and AI strategyWe asked 4 expert tech investors how to invest in AI without getting sucked in by the hype. Here's what they told us.
Weiterlesen »
Ex-Instagram employee says 'impatience' hurt Meta shopping effortsInsider tells the global tech, finance, markets, media, healthcare, and strategy stories you want to know.
Weiterlesen »